{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:14:07Z","timestamp":1786515247779,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Carolinas Muscular Dystrophy Research Endowment at the Atrium Health Foundation"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.omtm.2019.12.005","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:02:44Z","timestamp":1577145764000},"page":"271-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["ISPD Overexpression Enhances Ribitol-Induced Glycosylation of \u03b1-Dystroglycan in Dystrophic FKRP Mutant Mice"],"prefix":"10.1016","volume":"17","author":[{"given":"Marcela P.","family":"Cataldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Blaeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi Long","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.12.005_bib1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10038-006-0056-7","article-title":"The genetic and molecular basis of muscular dystrophy: roles of cell-matrix linkage in the pathogenesis","volume":"51","author":"Kanagawa","year":"2006","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.omtm.2019.12.005_bib2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","article-title":"Membrane organization of the dystrophin-glycoprotein complex","volume":"66","author":"Ervasti","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2019.12.005_bib3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2019.12.005_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0092-8674(94)90052-3","article-title":"Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor","volume":"77","author":"Gee","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2019.12.005_bib5","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/emboj\/18.4.863","article-title":"Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins","volume":"18","author":"Talts","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.omtm.2019.12.005_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1083\/jcb.200105003","article-title":"A stoichiometric complex of neurexins and dystroglycan in brain","volume":"154","author":"Sugita","year":"2001","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2019.12.005_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/glycob\/cwv021","article-title":"Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane","volume":"25","author":"Yoshida-Moriguchi","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.omtm.2019.12.005_bib8","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1086\/324412","article-title":"Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan","volume":"69","author":"Brockington","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2019.12.005_bib9","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1136\/jmg.2003.013870","article-title":"Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome","volume":"41","author":"Beltran-Valero de Bernab\u00e9","year":"2004","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.omtm.2019.12.005_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature00837","article-title":"Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies","volume":"418","author":"Michele","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2019.12.005_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ana.10559","article-title":"Phenotypic spectrum associated with mutations in the fukutin-related protein gene","volume":"53","author":"Mercuri","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2019.12.005_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archneur.63.2.251","article-title":"Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations","volume":"63","author":"Mercuri","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.omtm.2019.12.005_bib13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0002-9440(10)63160-4","article-title":"Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies","volume":"164","author":"Brown","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2019.12.005_bib14","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.ajpath.2016.02.015","article-title":"Glucocorticoid Steroid and Alendronate Treatment Alleviates Dystrophic Phenotype with Enhanced Functional Glycosylation of \u03b1-Dystroglycan in Mouse Model of Limb-Girdle Muscular Dystrophy with FKRPP448L Mutation","volume":"186","author":"Wu","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2019.12.005_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.omtm.2017.02.002","article-title":"Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP Gene","volume":"5","author":"Vannoy","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2019.12.005_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.omtm.2018.10.004","article-title":"Dose-Dependent Effects of FKRP Gene-Replacement Therapy on Functional Rescue and Longevity in Dystrophic Mice","volume":"11","author":"Vannoy","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2019.12.005_bib17","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.celrep.2016.02.017","article-title":"Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy","volume":"14","author":"Kanagawa","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2019.12.005_bib18","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1038\/ncomms11534","article-title":"ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto \u03b1-dystroglycan","volume":"7","author":"Gerin","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2019.12.005_bib19","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.chembiol.2015.10.014","article-title":"Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation","volume":"22","author":"Riemersma","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.omtm.2019.12.005_bib20","doi-asserted-by":"crossref","first-page":"e14473","DOI":"10.7554\/eLife.14473","article-title":"The functional O-mannose glycan on \u03b1-dystroglycan contains a phospho-ribitol primed for matriglycan addition","volume":"5","author":"Praissman","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.omtm.2019.12.005_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/brain\/aws312","article-title":"ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies","volume":"136","author":"Cirak","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.omtm.2019.12.005_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng.2252","article-title":"ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome","volume":"44","author":"Willer","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2019.12.005_bib23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ng.2253","article-title":"Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of \u03b1-dystroglycan","volume":"44","author":"Roscioli","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2019.12.005_bib24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.0b013e3182840cbc","article-title":"Limb-girdle muscular dystrophy with \u03b1-dystroglycan deficiency and mutations in the ISPD gene","volume":"80","author":"Tasca","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2019.12.005_bib25","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1038\/s41467-018-05990-z","article-title":"Ribitol restores functionally glycosylated \u03b1-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice","volume":"9","author":"Cataldi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2019.12.005_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther"},{"key":"10.1016\/j.omtm.2019.12.005_bib27","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1093\/hmg\/ddq314","article-title":"Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies","volume":"19","author":"Chan","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.12.005_bib28","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00439-013-1302-7","article-title":"Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes","volume":"132","author":"Blaeser","year":"2013","journal-title":"Hum. Genet."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119301548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119301548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:26:32Z","timestamp":1762421192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050119301548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":28,"alternative-id":["S2329050119301548"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.12.005","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ISPD Overexpression Enhances Ribitol-Induced Glycosylation of \u03b1-Dystroglycan in Dystrophic FKRP Mutant Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}